Trade AstraZeneca PLC - GBP - AZNl CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.32 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.025295% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.003377% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.65 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 119.87 |
| Open | 121.67 |
| 1-Year Change | 13.51% |
| Day's Range | 121.15 - 123.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 119.68 | -3.19 | -2.60% | 122.87 | 122.93 | 114.46 |
| Jul 24, 2024 | 122.01 | 0.24 | 0.20% | 121.77 | 122.29 | 120.21 |
| Jul 23, 2024 | 119.87 | -1.90 | -1.56% | 121.77 | 123.55 | 119.87 |
| Jul 22, 2024 | 122.35 | 0.28 | 0.23% | 122.07 | 123.41 | 121.55 |
| Jul 19, 2024 | 121.05 | 0.58 | 0.48% | 120.47 | 121.75 | 119.85 |
| Jul 18, 2024 | 121.07 | -1.56 | -1.27% | 122.63 | 123.63 | 120.97 |
| Jul 17, 2024 | 122.35 | 1.62 | 1.34% | 120.73 | 122.37 | 119.16 |
| Jul 16, 2024 | 119.49 | -0.56 | -0.47% | 120.05 | 120.81 | 119.49 |
| Jul 15, 2024 | 120.71 | -1.24 | -1.02% | 121.95 | 122.57 | 120.71 |
| Jul 12, 2024 | 122.41 | 1.00 | 0.82% | 121.41 | 122.89 | 121.41 |
| Jul 11, 2024 | 120.11 | -0.94 | -0.78% | 121.05 | 121.47 | 120.11 |
| Jul 10, 2024 | 120.43 | 0.83 | 0.69% | 119.60 | 120.53 | 119.42 |
| Jul 9, 2024 | 118.88 | -1.19 | -0.99% | 120.07 | 121.05 | 118.88 |
| Jul 8, 2024 | 120.09 | 0.22 | 0.18% | 119.87 | 121.05 | 119.87 |
| Jul 5, 2024 | 119.36 | -1.47 | -1.22% | 120.83 | 121.71 | 119.36 |
| Jul 4, 2024 | 121.01 | 0.74 | 0.62% | 120.27 | 121.65 | 120.17 |
| Jul 3, 2024 | 119.79 | -1.26 | -1.04% | 121.05 | 121.15 | 119.58 |
| Jul 2, 2024 | 120.69 | -1.30 | -1.07% | 121.99 | 122.75 | 120.27 |
| Jul 1, 2024 | 122.87 | -0.62 | -0.50% | 123.49 | 123.73 | 122.15 |
| Jun 28, 2024 | 123.77 | 2.60 | 2.15% | 121.17 | 124.39 | 121.17 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - GBP Company profile
About AstraZeneca plc
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.
| Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com